Homologue disjunction in mouse oocytes requires proteolysis of securin and cyclin B1

被引:164
作者
Herbert, M
Levasseur, M
Homer, H
Yallop, K
Murdoch, A
McDougall, A
机构
[1] Int Ctr Life, Biosci Ctr, Sch Surg & Reprod Sci, Cell & Dev Physiol Res Grp, Newcastle Upon Tyne NE1 4EP, Tyne & Wear, England
[2] Med Sch Newcastle Upon Tyne, Sch Cell & Mol Biosci, Cell & Dev Physiol Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England
[3] Int Ctr Life, Biosci Ctr, Newcastle Fertil Ctr, Newcastle Upon Tyne NE1 4EP, Tyne & Wear, England
关键词
D O I
10.1038/ncb1062
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Disjunction of pairs of homologous chromosomes during the first meiotic division (MI) requires anaphase-promoting complex (APC)-mediated activation of separase in budding yeast(1,2) and Caenorhabditis elegans(3,4,5), but not Xenopus laevis(6,7). It is not clear which model best fits the mammalian system. Here we show that homologue disjunction in mouse oocytes is dependent on proteolysis of the separase inhibitor securin and the Cdk1 regulatory sub-unit cyclin B1. Proteolysis of both proteins was entirely dependent on their conserved destruction box (D-box) motifs, through which they are targeted to the APC(8). These data indicate that the mechanisms regulating homologue disjunction in mammalian oocytes are similar to those of budding yeast and C. elegans.
引用
收藏
页码:1023 / 1025
页数:3
相关论文
共 17 条
  • [1] Disjunction of homologous chromosomes in meiosis I depends on proteolytic cleavage of the meiotic cohesin Rec8 by separin
    Buonomo, SBC
    Clyne, RK
    Fuchs, J
    Loidl, J
    Uhlmann, F
    Nasmyth, K
    [J]. CELL, 2000, 103 (03) : 387 - 398
  • [2] Detection of mosaic and non-mosaic chromosome abnormalities in 6- to 8-day-old human blastocysts
    Clouston, HJ
    Fenwick, J
    Webb, AL
    Herbert, M
    Murdoch, A
    Wolstenholme, J
    [J]. HUMAN GENETICS, 1997, 101 (01) : 30 - 36
  • [3] Ama1p is a meiosis-specific regulator of the anaphase promoting complex/cyclosome in yeast
    Cooper, KF
    Mallory, MJ
    Egeland, DB
    Jarnik, M
    Strich, R
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (26) : 14548 - 14553
  • [4] hpttg, a human homologue of rat pttg, is overexpressed in hematopoietic neoplasms.: Evidence for a transcriptional activation function of hPTTG
    Domínguez, A
    Ramos-Morales, F
    Romero, F
    Rios, RM
    Dreyfus, F
    Tortolero, M
    Pintor-Toro, JA
    [J]. ONCOGENE, 1998, 17 (17) : 2187 - 2193
  • [5] EMB30:: An APC4 homologue required for metaphase-to-anaphase transitions during meiosis and mitosis in Caenorhabditis elegans
    Furuta, T
    Tuck, S
    Kirchner, J
    Koch, B
    Auty, R
    Kitagawa, R
    Rose, AM
    Greenstein, D
    [J]. MOLECULAR BIOLOGY OF THE CELL, 2000, 11 (04) : 1401 - 1419
  • [6] Metaphase to anaphase (mat) transition-defective Mutants in Caenorhabditis elegans
    Golden, A
    Sadler, PL
    Wallenfang, MR
    Schumacher, JM
    Hamill, DR
    Bates, G
    Bowerman, B
    Seydoux, G
    Shakes, DC
    [J]. JOURNAL OF CELL BIOLOGY, 2000, 151 (07) : 1469 - 1482
  • [7] Human securin proteolysis is controlled by the spindle checkpoint and reveals when the APC/C switches from activation by Cdc20 to Cdh1
    Hagting, A
    den Elzen, N
    Vodermaier, HC
    Waizenegger, IC
    Peters, JM
    Pines, J
    [J]. JOURNAL OF CELL BIOLOGY, 2002, 157 (07) : 1125 - 1137
  • [8] To ERR (meiotically) is human: The genesis of human aneuploidy
    Hassold, T
    Hunt, P
    [J]. NATURE REVIEWS GENETICS, 2001, 2 (04) : 280 - 291
  • [9] Acquisition of meiotic competence in mouse oocytes:: Absolute amounts of p34cdc2, cyclin b1, cdc25C, and wee1 in meiotically incompetent and competent oocytes
    Kanatsu-Shinohara, M
    Schultz, RM
    Kopf, GS
    [J]. BIOLOGY OF REPRODUCTION, 2000, 63 (06) : 1610 - 1616
  • [10] Meiotic maturation of the mouse oocyte requires an equilibrium between cyclin B synthesis and degradation
    Ledan, E
    Polanski, Z
    Terret, ME
    Maro, B
    [J]. DEVELOPMENTAL BIOLOGY, 2001, 232 (02) : 400 - 413